US-FDA cleared ComASP® Cefiderocol

The ComASP® Cefiderocol 0.008-128 is a quantitative broth microdilution method intended for the in vitro determination of antimicrobial susceptibility of bacteria. ComASP® Cefiderocol consists of polystyrene microtiter panels containing lyophilized concentrations of cefiderocol and tubes of media (iron-depleted, cation-adjusted Mueller Hinton broth), which are used to determine the minimum inhibitory concentration (MIC) in ?g/mL using overnight incubation and manual reading procedures. ComASP® Cefiderocol at concentrations of 0.008-128 ?g/mL should be interpreted at 16-20 hours of incubation.

ComASP® Cefiderocol can be used to determine the MIC of cefiderocol against the following microorganisms for which cefiderocol has been shown to be active clinically and in-vitro according to the FDA drug approved label:

Acinetobacter baumannii complex
Escherichia coli
Enterobacter cloacae complex
Klebsiella pneumoniae
Proteus mirabilis
Pseudomonas aeruginosa
Serratia marcescens

Download the product technical sheet of the US-FDA cleared item

ref. 75009U
4 panels/pack
2 tests/panel

Learn more about ComASP®